NewMet: Phase IIb started

Elcelyx began a double-blind, placebo-controlled, U.S. Phase IIb trial to compare 600, 800 and 1,000 mg NewMet vs. 1,000 and 2,000 mg extended-release metformin once daily in about 240 Type II diabeti...